A delivery system is a technology designed to transport a drug or therapeutic substance into your body and release it in a controlled way at the right location. In its simplest form, a tablet is a delivery system. In more advanced forms, delivery systems use engineered materials like nanoparticles, patches, and implants to get medications to precise targets while minimizing side effects. The core goal is always the same: maximize the benefit of a drug while reducing the amount that ends up where it’s not needed.
How Delivery Systems Work
Every medication needs a way to get from outside your body to the specific cells or tissues where it does its job. A delivery system handles that journey. It formulates and stores drug molecules in a suitable form, whether that’s a pill, a liquid injection, or a microscopic particle, and controls how and when the drug is released once it’s inside you.
Without a delivery system, many drugs would break down in your stomach, flood your bloodstream all at once, or never reach the tissue that actually needs them. The delivery system solves these problems by protecting the drug during transit, controlling the speed of release, and in some cases steering the drug toward a specific site like a tumor or an inflamed joint.
Common Types of Delivery Systems
Delivery systems range from everyday formats you’ve used your whole life to highly engineered technologies still being refined.
- Oral systems: Tablets, capsules, and liquid solutions. These are the most familiar. Some are designed to release a drug immediately, while others use coatings or layered structures to release it slowly over hours.
- Transdermal patches: Adhesive patches that deliver drugs through the skin. Nicotine patches, fentanyl patches for pain, nitroglycerin patches for chest pain, and estradiol patches for hormone therapy all use this approach. They provide a steady, continuous dose without needles.
- Injectable and implantable systems: Depot injections release a drug slowly over weeks or months from a single shot. Implants placed under the skin can deliver hormones or other medications for even longer periods.
- Nanoparticle systems: Tiny carriers measured in billionths of a meter that can encapsulate drugs and deliver them to very specific targets. These include lipid nanoparticles, liposomes, and polymer-based particles.
- Hydrogels: Water-absorbing polymer networks that swell and gradually release drugs. They’re used in wound care, eye treatments, and tissue engineering.
What Delivery Systems Are Made Of
The materials used to build delivery systems fall into a few broad categories. Polymers are the most common. Biodegradable polymers break down safely in the body over time, releasing the drug as they dissolve. Lipids, the same type of fat molecules found in cell membranes, are used to form tiny spheres called liposomes that can carry both water-soluble and fat-soluble drugs. Synthetic polymers like polyethylene glycol (PEG) improve how long a drug circulates in the bloodstream by preventing the immune system from clearing it too quickly.
The choice of material determines nearly everything about how a delivery system behaves: how fast it releases the drug, how long it lasts in the body, and whether it can target a specific tissue.
Controlled Release vs. Immediate Release
One of the most important distinctions in delivery systems is how they control timing. An immediate-release tablet dumps its entire drug payload at once. A controlled-release system meters it out gradually, keeping blood levels of the drug within a therapeutic range for hours, days, or even months.
This matters because many drugs are only effective within a narrow concentration window. Too little and they don’t work. Too much and they cause side effects. Controlled-release systems aim to maintain a steady level, but achieving this in practice is harder than it sounds. The biological environment inside your body, including differences in absorption along the digestive tract, can alter how the drug actually behaves compared to what lab tests predict.
Long-acting injectable formulations face a particular challenge called burst release, where up to 50% of the total drug escapes in the first day or two. This creates an initial spike in blood concentration that can be 100 times higher than the steady therapeutic level the system is designed to maintain. That spike isn’t medically necessary. It’s an artifact of manufacturing methods, and reducing it remains an active engineering problem.
How Targeting Works
Getting a drug to the right place in your body uses two broad strategies. Passive targeting takes advantage of natural biological conditions. Tumors, for example, tend to have leaky blood vessels that allow nanoparticles to accumulate in cancerous tissue more easily than in healthy tissue. This is known as the enhanced permeation and retention effect.
Active targeting goes further by attaching molecules to the surface of a drug carrier that bind specifically to receptors on diseased cells. Think of it as putting a mailing address on the package. This allows the system to distinguish between healthy and diseased tissue, delivering the drug more selectively to cancer cells, inflamed areas, or other targets while sparing the rest of the body.
Real-World Benefits for Patients
Advanced delivery systems offer several practical advantages. Reduced dosing frequency is one of the biggest. A drug that requires daily injections can sometimes be reformulated into a monthly depot injection, which makes it far easier to stay on treatment. Transdermal patches for insulin delivery are being developed as an alternative to daily injections, using microneedle arrays that painlessly penetrate the outer skin layer.
Fewer side effects are another major benefit. By directing more of the drug to where it’s needed and less to where it isn’t, delivery systems reduce off-target exposure. This is especially valuable in cancer treatment, where traditional chemotherapy harms healthy tissue alongside tumors. Localized delivery systems can concentrate the drug at the tumor site, lowering the dose that reaches the rest of the body.
These advantages often translate to cost savings as well. While advanced formulations can be more expensive per unit than a simple tablet, better adherence and fewer complications can reduce the overall economic burden of treatment.
Nanoparticle Delivery in Practice
Nanoparticle delivery systems gained widespread public attention through the mRNA COVID-19 vaccines, which used lipid nanoparticles to protect fragile genetic material and shuttle it into cells. But this technology was already in clinical use. In 2018, the FDA approved a lipid nanoparticle therapy for a rare hereditary nerve disease, making it one of the first approved treatments to use this carrier technology for delivering small interfering RNA, a type of genetic medicine that silences specific genes.
Liposomes, which are spherical lipid shells, have been used in approved cancer drugs for longer. They encapsulate chemotherapy agents, allowing higher concentrations to accumulate in tumors with less damage to the heart and other organs.
Smart Systems That Respond to the Body
A newer generation of delivery systems can sense conditions inside the body and release drugs in response. These “smart” systems react to triggers like changes in acidity (pH), temperature, enzyme levels, or glucose concentration. A glucose-responsive system, for instance, could theoretically release insulin only when blood sugar rises, mimicking how a healthy pancreas works.
Some smart systems respond to external triggers instead, releasing their payload when exposed to ultrasound, magnetic fields, or light applied from outside the body. This gives clinicians precise control over when and where the drug activates. Enzyme-responsive systems are particularly promising for cancer and inflammatory diseases, since diseased tissues often overproduce specific enzymes that can be used to unlock the drug carrier right at the site of disease.